Innes, Andrew J.

mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype

Herranz, N., Gallage, S., Mellone, M., Wuestefeld, T., Klotz, S., Hanley, C. J., Raguz, S., Acosta, J. C., Innes, A. J., Banito, A., et al. (2015) · Nature Cell Biology

Telomeres, Telomerase, and SenescenceGenetics, Aging, and Longevity in Model Organisms

Cited by 788

Cardiac glycosides are broad-spectrum senolytics

Guerrero, A., Herranz, N., Sun, B., Wagner, V., Gallage, S., Guiho, R., Wolter, K., Pombo, J., Irvine, E. E., Innes, A. J., et al. (2019) · Nature Metabolism

Telomeres, Telomerase, and SenescenceGenetics, Aging, and Longevity in Model Organisms

Cited by 359

XPO7 is a tumor suppressor regulating p21CIP1-dependent senescence

Innes, A. J., Sun, B., Wagner, V., Brookes, S., McHugh, D., Pombo, J., Porreca, R. M., Dharmalingam, G., Vernia, S., Zuber, J., et al. (2021) · Genes & Development

Telomeres, Telomerase, and SenescenceNuclear Structure and Function

Cited by 30

Long-term outcomes after upfront second-generation tyrosine kinase inhibitors for chronic myeloid leukemia: managing intolerance and resistance

Claudiani, S., Chughtai, F., Khan, A., Hayden, C., Fernando, F., Khorashad, J., Orovboni, V., Scandura, G., Innes, A., Apperley, J. F., et al. (2024) · Leukemia

Chronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia Research

Cited by 26

Effect of tyrosine kinase inhibitors on male fertility in patients with chronic phase chronic myeloid leukemia

Nesr, G., Claudiani, S., Milojkovic, D., Innes, A., Fernando, F., Caballes, I., Mungozi, P., Szydlo, R., Lovato, S., Jayasena, C., et al. (2024) · Leukemia & Lymphoma

Chronic Myeloid Leukemia TreatmentsSperm and Testicular Function

Cited by 14

Expectations and outcomes of varying treatment strategies for CML presenting during pregnancy

Robertson, H. F., Milojkovic, D., Butt, N., Byrne, J., Claudiani, S., Copland, M., Gallipoli, P., Innes, A. J., Knight, K., Mahdi, A. J., et al. (2024) · British Journal of Haematology

Chronic Myeloid Leukemia TreatmentsPregnancy and Medication Impact

Cited by 13

Impact of BCR::ABL1 single nucleotide variants on asciminib efficacy

Innes, A. J., Hayden, C., Orovboni, V., Claudiani, S., Fernando, F., Khan, A., Rees, D., Byrne, J., Gallipoli, P., Francis, S., et al. (2024) · Leukemia

Chronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia Research

Cited by 13

Treatment‐free remission in CML patients with additional chromosome abnormalities in the Philadelphia‐positive clone or variant Philadelphia translocations

Claudiani, S., Chee, L., Fernando, F., Brown, L., Achandira, U. M., Khan, A., Rothwell, K., Hayden, C., Koutsavlis, I., Hannah, G., et al. (2024) · American Journal of Hematology

Chronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia Research

Cited by 4